A prospective study of urinary oestrogen excretion and breast cancer risk

British Journal of Cancer

Volumn 73, Issue 12, 1996, Pages 1615-1619

  Key, T J A ^a   Wang, D Y ^b   Brown, J B ^c   Hermon, C ^a   Allen, D S ^d   Moore, J W ^d   Bulbrook, R D ^d   Fentiman, I S ^e   Pike, M C ^f  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e GUY S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Breast cancer risk; Prospective study; Urinary oestrogen

Indexed keywords

ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ESTROGEN URINE LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; STATISTICAL ANALYSIS;

EID: 0030036376     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.304     Document Type: Article

References (28)

1. ARGÜELLES AE, POGGI UL, SABORIDA C, HUFFMAN C, CHEKHERDEMIAN M AND BLANCHARDO O. (1973). Endocrine profiles and breast cancer. Lancet, 1, 165-168.
2. BERNSTEIN L, ROSS RK, PIKE MC, BROWN JB AND HENDERSON BE. (1990a). Hormone levels in older women: a study of postmenopausal breast cancer patients and healthy population controls. Br. J. Cancer, 61, 298-302.
3. BERNSTEIN L, YUAN JM, ROSS RK, PIKE MC, HANISCH R, LOBO R, STANCZYK F, GAO Y-T AND HENDERSON BE. (1990b). Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes and Control, 1, 51-58.
4. BINGHAM SA, WILLIAMS R, COLE TJ. PRICE CP AND CUMMINGS JH. (1988). Reference values for analytes of 24-h urine collections known to be complete. Ann. Clin. Biochem., 25, 610-619.
5. BROWN JB. (1976). Determination of estriol, estrone and estradiol-17β in nonpregnancy urine by spectrophotometry or fluorimetry. In Methods of Hormone Analysis, Breuer H, Hamel D and Kruskemper HL (eds) p 446. Wiley: New York.
6. BRUNING PF, BONFRER JMG AND HART AAM. (1985). Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk. Br. J. Cancer, 51, 479-484.
7. COLE P, CRAMER D, YEN S, PAFFENBARGER R, MACMAHON B AND BROWN J. (1978). Estrogen profiles of premenopausal women with breast cancer. Cancer Res., 38, 745-748.
8. DRAFTA D, SCHINDLER AE, MILCU ST M, KELLER E, STROE E, HORODNICEANU E AND BALANESCU I. (1980). Plasma hormones in pre- and postmenopausal breast cancer. J. Steroid Biochem.,43, 793-802.
9. ENGLAND PC, SKINNER LG, COTTRELL KM AND SELLWOOD RA. (1974). Serum oestradiol-17β in women with benign and malignant breast disease. Br. J. Cancer, 30, 571-576.
10. GARLAND CF, FRIEDLANDER NJ, BARRETT-CONNOR E AND KHAW K-T. (1992). Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am. J. Epidemiol., 135, 1220-1230.
11. GRODIN JM, SIITERI PK AND MACDONALD PC. (1973). Source of estrogen production in postmenopausal women. J. Clin. Endocrinol. Metab., 36, 207-214.
12. HELZLSOUER KJ, ALBERG AJ, BUSH TL, LONGCOPE C, GORDON GB AND COMSTOCK GW. (1994). A prospective study of endogenous hormones and breast cancer. Cancer Detection Prevention, 18, 79-85.
13. JUDD HL, SHAMONKI IM, FRUMAR AM AND LAGASSE LD. (1982). Origin of serum estradiol in postmenopausal women. Obstet. Gynecol., 59, 680-686.
14. KEY TJA AND PIKE MC. (1988). The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur. J. Cancer Clin. Oncol., 24, 29-43.
15. MACMAHON B, COLE P, BROWN JB, PAFFENBARGER R, TRICHOPOULOS D AND YEN S. (1983). Urine estrogens, frequency of ovulation, and breast cancer risk: case-control study in premenopausal women. J. Natl. Cancer Inst., 70, 247-250.
16. MALARKEY WB, SCHROEDER LL, STEVENS VC, JAMES AG AND LANESE RR. (1977). Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res., 37, 4655-4659.
17. MARMORSTON J, CROWLEY LG, MYERS SM, STERN E AND HOPKINS CE. (1965). Urinary excretion of estrone, estradiol, and estriol by patients with breast cancer and benign breast disease. Am. J. Obstet. Gynecol., 4, 460-467.
18. MEYER F, BROWN JB, MORRISON AS AND MACMAHON B. (1986). Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J. Natl. Cancer Inst., 77, 613-616.
19. MOORE JW, CLARK GMG, BULBROOK RD, HAYWARD JL, MURAI JT, HAMMOND GL AND SIITERI PK. (1982). Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls. Int. J. Cancer, 29, 17-21.
20. MOORE JW, CLARK GMG, HOARE SA, MILLIS RR, HAYWARD JL, QUINLAN MK, WANG DY AND BULBROOK RD. (1986). Binding of oestradiol to blood proteins and aetiology of breast cancer. Int. J. Cancer, 38, 625-630.
21. PERSSON BH AND RISHOLM L. (1964). Oophorectomy and cortisone treatment as a method of eliminating oestrogen production in patients with breast cancer. Acta Endocrinol., 47, 15-26.
22. ROSENBERG CR, PASTERNACK BS, SHORE RE, KOENIG KL AND TONIOLO PG. (1994). Premenopausal estradiol levels and the risk of breast cancer. A new method of controlling for day of the menstrual cycle. Am. J. Epidemiol., 140, 518-525.
23. SHERMAN BM, WALLACE RB AND JOCHIMSEN PR. (1979). Hormonal regulation of the menstrual cycle in women with breast cancer: effect of adjuvant chemotherapy. Clin. Endocrinol., 10, 287-296.
24. SIITERI PK, SIMBERG N AND MURAI J. (1986). Estrogens and breast cancer. Ann. N. Y. Acad. Sci., 464, 100-105.
25. TONIOLO PG, LEVITZ M, ZELENIUCH-JACQUOTTE A, BANERJEE S, KOENIG KL, SHORE RE, STRAX P AND PASTERNACK BS. (1995). A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl. Cancer Inst., 87, 190-197.
26. WANG DY, DE STAVOLA BL, BULBROOK RD, ALLEN DS, KWA HG, FENTIMAN IS, HAYWARD JL AND MILLIS RR. (1992). Relationship of blood prolactin levels and the risk of subsequent breast cancer. Int. J. Epidemiol., 21, 214-221.
27. WYSOWSKI DK, COMSTOCK GW, HELSING KJ AND LAU HL. (1987). Sex hormone levels in serum in relation to the development of breast cancer. Am. J. Epidemiol., 125, 791-799.
28. ZARIDZE D, KUSHLINSKII N, MOORE JW, LIFANOVA Y, BASSALYK L AND WANG DY. (1992). Endogenous plasma sex hormones in pre- and postmenopausal women with breast cancer: results from a case-control study in Moscow. European Journal of Cancer Prevention, 1, 225-230.